Tag: NASDAQ:ITRM

March 31, 2019

5 Top Weekly NASDAQ Biotech Stocks: Index Rebounds

Aveo Pharmaceuticals, Curis, Phasebio Pharmaceuticals, Arcturus Therapeutics and Krystal Biotech were last week's top gainers.
December 16, 2018

5 Top Weekly NASDAQ Biotech Stocks: Innovate Leads the Pack

Innovate Biopharmaceuticals, Aridis Pharmaceuticals, Imprimis Pharmaceuticals, Achaogen and SynthoRx were last week's top gainers.
November 14, 2018

Iterum Reports Third Quarter 2018 Financial Results and Recent Highlights

Iterum Therapeutics (Nasdaq:ITRM), a clinical-stage pharmaceutical company developing anti-infectives against multi-drug resistant pathogens, today reported financial results for the quarter...
September 18, 2018

Iterum Initiates SURE 2 and SURE 3 Phase 3 Clinical Trials of IV and Oral Sulopenem in Complicated Urinary Tract and Complicated Intra-abdominal Infections

Iterum Therapeutics (Nasdaq:ITRM), a clinical-stage pharmaceutical company developing antibiotics against multi-drug resistant pathogens, today announced its initiation of the second...
August 10, 2018

Iterum Initiates SURE 1, a Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections

Iterum Therapeutics (Nasdaq:ITRM), a clinical-stage pharmaceutical company developing antibiotics against multi-drug resistant pathogens, today announced its initiation of the first...
June 4, 2018

6 Top Life Science IPOs From May

Some benefits of companies going public include: values for securities can be established, increased access to capital-raising opportunities, and expanding...